基于深度学习剂量预测与正常组织并发症概率模型的自动化临床决策支持系统用于评估食管癌患者治疗并发症
本研究构建两个U-Net分别预测光子与质子调强放疗剂量分布,并与术后肺部并发症NTCP模型串联形成自动化决策流程,以ΔNTCP≥10%为阈值将患者转诊质子治疗;深度学习模型对肺平均剂量预测误差光子为1.14±0.93%、质子为0.66±0.48%,完整自动化流程患者转诊准确率达100%。
要点
- 深度学习剂量预测模型对肺平均剂量的平均误差光子为1.14±0.93%、质子为0.66±0.48%。
- 深度学习与NTCP模型串联的自动化流程在患者转诊中达到100%准确率。
- ΔNTCP残差平均为1.43±1.49%,ΔNTCP≥10%的患者被转诊至质子治疗。
核心结论
- 本研究在更广泛的患者转诊背景下评估了深度学习剂量预测模型,并证明其能够支持临床决策。
研究设计与样本
- 研究为方法学开发与评估,创建两个U-Net分别用于光子(XT)和质子(PT)计划,在40例统一计划患者数据库上采用交叉验证和循环测试集进行训练。
主要发现
- 深度学习模型预测剂量分布时,肺平均剂量(MLD)的平均误差光子为1.14±0.93%,质子为0.66±0.48%。
- 完整自动化流程(深度学习串联NTCP)在患者转诊中达到100%准确率。
- ΔNTCP残差(真实值减预测值)平均为1.43±1.49%。
关键数值与推荐
- NTCP模型用于术后肺部并发症,预测变量包括平均肺剂量、年龄、组织学类型和体重指数。
- 治疗选择通过光子与质子计划之间的ΔNTCP阈值确定,ΔNTCP≥10%的患者被转诊至质子治疗。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: This study aims to investigate how accurate our deep learning (DL) dose prediction models for intensity modulated radiotherapy (IMRT) and pencil beam scanning (PBS) treatments, when chained with normal tissue complication probability (NTCP) models, are at identifying esophageal cancer patients who are at high risk of toxicity and should be switched to proton therapy (PT). MATERIALS AND METHODS: Two U-Net were created, for photon (XT) and proton (PT) plans, respectively. To estimate the dose distribution for each patient, they were trained on a database of 40 uniformly planned patients using cross validation and a circulating test set. These models were combined with a NTCP model for postoperative pulmonary complications. The NTCP model used the mean lung dose, age, histology type, and body mass index as predicting variables. The treatment choice is then done by using a ΔNTCP threshold between XT and PT plans. Patients with ΔNTCP ≥ 10% were referred to PT. RESULTS: Our DL models succeed in predicting dose distributions with a mean error on the mean dose to the lungs (MLD) of 1.14 ± 0.93% for XT and 0.66 ± 0.48% for PT. The complete automated workflow (DL chained with NTCP) achieved 100% accuracy in patient referral. The average residual (ΔNTCP ground truth - ΔNTCP predicted) is 1.43 ± 1.49%. CONCLUSION: This study evaluates our DL dose prediction models in a broader patient referral context and demonstrates their ability to support clinical decisions.
引用
- Draguet C, Barragán-Montero AM, Vera MC, et al. Automated clinical decision support system with deep learning dose prediction and NTCP models to evaluate treatment complications in patients with esophageal cancer. Radiother Oncol. 2022. PMID: 36167194. doi:10.1016/j.radonc.2022.08.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。